NYSEMKT:BIOX - Bioceres Crop Solutions Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $23.00
  • Forecasted Upside: 73.58 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$13.25
▼ -0.05 (-0.38%)

This chart shows the closing price for BIOX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bioceres Crop Solutions Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BIOX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BIOX

Analyst Price Target is $23.00
▲ +73.58% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Bioceres Crop Solutions in the last 3 months. The average price target is $23.00, with a high forecast of $25.00 and a low forecast of $21.00. The average price target represents a 73.58% upside from the last price of $13.25.

This chart shows the closing price for BIOX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in Bioceres Crop Solutions.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/21/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/8/2021Roth CapitalInitiated CoverageBuy$21.00
9/10/2021Lake Street CapitalReiterated RatingBuy$25.00
5/7/2021Brookline Capital ManagementReiterated RatingBuy
4/8/2021Lake Street CapitalBoost Price TargetBuy$15.00 ➝ $20.00
3/15/2021Lake Street CapitalInitiated CoverageBuy$15.00
2/4/2020Brookline Capital ManagementReiterated RatingBuy
(Data available from 10/21/2016 forward)

News Sentiment Rating

0.44 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/23/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/21/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/21/2021

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Bioceres Crop Solutions logo
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. The company operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. In addition, the company offers HB4, a drought tolerant seed technology program. It operates in Argentina, Austria, Bolivia, Brazil, Lebanon, the United States, Italy, Paraguay, the United Kingdom, South Africa, France, Canada, Ukraine, Uruguay, and internationally. The company is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
Read More

Today's Range

Now: $13.25
Low: $13.22
High: $13.35

50 Day Range

MA: $13.34
Low: $12.40
High: $13.99

52 Week Range

Now: $13.25

Volume

6,710 shs

Average Volume

20,179 shs

Market Capitalization

$532.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Frequently Asked Questions

What sell-side analysts currently cover shares of Bioceres Crop Solutions?

The following Wall Street research analysts have issued reports on Bioceres Crop Solutions in the last twelve months: Brookline Capital Management, Lake Street Capital, and Roth Capital.
View the latest analyst ratings for BIOX.

What is the current price target for Bioceres Crop Solutions?

2 Wall Street analysts have set twelve-month price targets for Bioceres Crop Solutions in the last year. Their average twelve-month price target is $23.00, suggesting a possible upside of 73.6%. Lake Street Capital has the highest price target set, predicting BIOX will reach $25.00 in the next twelve months. Roth Capital has the lowest price target set, forecasting a price of $21.00 for Bioceres Crop Solutions in the next year.
View the latest price targets for BIOX.

What is the current consensus analyst rating for Bioceres Crop Solutions?

Bioceres Crop Solutions currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BIOX will outperform the market and that investors should add to their positions of Bioceres Crop Solutions.
View the latest ratings for BIOX.

How do I contact Bioceres Crop Solutions' investor relations team?

Bioceres Crop Solutions' physical mailing address is Ocampo 210 bis Predio CCT, Rosario C1, 2000. The company's listed phone number is 54 34 1486 1100 and its investor relations email address is [email protected] The official website for Bioceres Crop Solutions is biocerescrops.com.